Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?

被引：0
|
作者：
Hachulla, E. [1 ]
机构：
[1] Hop Claude Huriez, Ctr Reference Malad Autoimmunes & Autoinflammatoi, Serv Med Interne & Immunol Clin, F-59037 Lille, France
来源：
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 12期
关键词：
Nintedanib; Systemic sclerosis; Interstitial lung disease; SCLERODERMA LUNG; CONTROLLED-TRIAL; PLACEBO; CYCLOPHOSPHAMIDE;
D O I：
10.1016/j.revmed.2019.08.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 777
页数：3
相关论文
共 50 条
  • [1] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [2] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Distler, Oliver
    Highland, Kristin B.
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen D.
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Tetzlaff, Kay
    Kuwana, Masataka
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26): : 2518 - 2528
  • [3] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E755 - E755
  • [4] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Rahimi, Susan
    LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 136 - 136
  • [5] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Andreasson, Kristofer
    Wuttge, Dirk M.
    Wollheim, Frank A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1595 - 1596
  • [6] Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease
    Wollin, Lutz
    Distler, Joerg H. W.
    Denton, Christopher P.
    Gahlemann, Martina
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (03) : 212 - 218
  • [7] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
    Distler, Oliver
    Gahlemann, Martina
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
  • [8] RECURRENT SPONTANEOUS PNEUMOTHORAX UNDER NINTEDANIB TREATMENT IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Senel, Abdurrahman Soner
    Denizhan, Tugba Kahraman
    Kiziltepe, Melih
    Kokoglu, Emel Oguz
    Tutar, Nuri
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (04)
  • [9] THE STUDY OF NINTEDANIB EFFICACY IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Desinova, Oxana
    Shayakhmetova, Rushana
    CHEST, 2023, 164 (04) : 5480A - 5481A
  • [10] Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug
    Kafle, Sunam
    Magar, Manusha Thapa
    Patel, Priyanka
    Poudel, Arisa
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
12345